News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Kim M. Hirshfield

Articles by Kim M. Hirshfield

TPS 99 Phase 3, Randomized, Open-Label TroFuse-010 Study of Sacituzumab Tirumotecan Alone and With Pembrolizumab Versus Treatment of Physician’s Choice Chemotherapy in Patients With HR+/HER2– Unresectable Locally Advanced or Metastatic Breast Cancer

BySara M. Tolaney, MD, MPH,Paolo D’Amico,Liyi Jia,Kim M. Hirshfield,Fatima Cardoso

April 16th 2025

Latest Updated Articles

Trending on CancerNetwork

ASCO Releases New Patient-Clinician Communication Guidelines

What is The State of Radiation Oncology in Head and Neck Cancers?

NCCN Guidelines Recommend Taletrectinib for ROS1+ NSCLC Subtype

Elranatamab Significantly Improves PFS in R/R Multiple Myeloma Trial

Melanoma Vaccine Receives FDA Fast Track Designation